Risk factors of postoperative intensive care unit admission during the COVID-19 pandemic: A multicentre retrospective cohort study
Ellen de Bock(University Medical Center Utrecht), Milan C. Richir(Utrecht University), Joost T. Heikens(Elisabeth-TweeSteden Ziekenhuis), Djamila Boerma(St. Antonius Ziekenhuis), Mando D. Filipe(University Medical Center Utrecht), Eline S. Herman(University Medical Center Utrecht), Paul M. Verheijen(Meander Medisch Centrum), Apollo Pronk(Diakonessenhuis hospital), Menno R. Vriens(University Medical Center Utrecht)
Cited by 0
Related Papers
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
|The Lancet Oncology|2018|582
The Dutch Surgical Colorectal Audit
|European Journal of Surgical Oncology|2013|362
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
|The Lancet. Gastroenterology & hepatology|2019|326
Long-term Outcome After Laparoscopic Ventral Mesh Rectopexy
|Annals of Surgery|2015|198